AL
VCSH icon

Aspiriant LLC’s Vanguard Short-Term Corporate Bond ETF VCSH Stock Holding History

Aspiriant LLC’s Portfolio VCSH Stock Details VCSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$312K Sell
3,942
-221
-5% -$17.6K 0.01% 271
2025
Q4 		$332K Sell
4,163
-64
-2% -$5.11K 0.01% 264
2025
Q3 		$338K Sell
4,227
-1,057
-20% -$84.1K 0.01% 238
2025
Q2 		$420K Sell
5,284
-3,303
-38% -$260K 0.01% 216
2025
Q1 		$678K Sell
8,587
-729
-8% -$57.2K 0.02% 164
2024
Q4 		$727K Buy
9,316
+1,834
+25% +$144K 0.03% 165
2024
Q3 		$594K Hold
7,482
– – 0.02% 178
2024
Q2 		$578K Hold
7,482
– – 0.02% 180
2024
Q1 		$578K Sell
7,482
-465
-6% -$35.9K 0.02% 182
2023
Q4 		$615K Hold
7,947
– – 0.03% 172
2023
Q3 		$597K Sell
7,947
-839
-10% -$63.3K 0.03% 166
2023
Q2 		$665K Sell
8,786
-92
-1% -$6.99K 0.03% 166
2023
Q1 		$677K Buy
8,878
+440
+5% +$33.3K 0.04% 155
2022
Q4 		$634K Sell
8,438
-26,025
-76% -$1.94M 0.03% 160
2022
Q3 		$2.56M Sell
34,463
-118
-0.3% -$8.99K 0.13% 71
2022
Q2 		$2.64M Buy
34,581
+785
+2% +$60.3K 0.13% 72
2022
Q1 		$2.64M Hold
33,796
– – 0.15% 70
2021
Q4 		$2.75M Sell
33,796
-68
-0.2% -$5.56K 0.15% 75
2021
Q3 		$2.79M Sell
33,864
-155
-0.5% -$12.8K 0.16% 66
2021
Q2 		$2.81M Sell
34,019
-612
-2% -$50.6K 0.16% 66
2021
Q1 		$2.86M Sell
34,631
-1,436
-4% -$119K 0.18% 54
2020
Q4 		$3M Sell
36,067
-2,481
-6% -$206K 0.2% 48
2020
Q3 		$3.19M Sell
38,548
-2,812
-7% -$233K 0.25% 47
2020
Q2 		$3.42M Sell
41,360
-10,070
-20% -$819K 0.32% 40
2020
Q1 		$4.07M Sell
51,430
-23,830
-32% -$1.92M 0.4% 35
2019
Q4 		$6.1M Sell
75,260
-3,269
-4% -$265K 0.56% 30
2019
Q3 		$6.36M Sell
78,529
-6,309
-7% -$510K 0.57% 35
2019
Q2 		$6.85M Sell
84,838
-18,337
-18% -$1.46M 0.57% 35
2019
Q1 		$8.23M Sell
103,175
-26,543
-20% -$2.09M 0.67% 32
2018
Q4 		$10.1M Sell
129,718
-40,848
-24% -$3.18M 0.77% 29
2018
Q3 		$13.3M Sell
170,566
-25,967
-13% -$2.03M 1.14% 21
2018
Q2 		$15.3M Sell
196,533
-7,701
-4% -$602K 1.31% 21
2018
Q1 		$16M Buy
204,234
+181,119
+784% +$14.3M 1.4% 19
2017
Q4 		$1.83M Sell
23,115
-197,269
-90% -$15.7M 0.54% 31
2017
Q3 		$17.7M Sell
220,384
-8,975
-4% -$719K 1.48% 22
2017
Q2 		$18.4M Sell
229,359
-10,774
-4% -$861K 1.6% 20
2017
Q1 		$19.1M Buy
+240,133
New +$19.1M 1.63% 20

Other funds holding VCSH

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

Aspiriant LLC's VCSH Position: Q1 2026 in Review

Aspiriant LLC reduced its Vanguard Short-Term Corporate Bond ETF (VCSH) stake by 5.3% in Q1 2026, selling an estimated $17.6K and leaving 3,942 shares worth $312K. The position accounts for 0.01% of the portfolio, ranked #271.

Aspiriant LLC first reported a position in VCSH in Q1 2017 and has held it in 37 quarters since. The position peaked at $19.1M in Q1 2017. 1,456 funds tracked by Wall St. Rank hold VCSH as of Q1 2026.

  • Aspiriant LLC held 3,942 shares of Vanguard Short-Term Corporate Bond ETF worth $312K as of Q1 2026.
  • Aspiriant LLC sold 221 Vanguard Short-Term Corporate Bond ETF shares in Q1 2026, an estimated $17.6K.
  • Vanguard Short-Term Corporate Bond ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #271 holding.
  • Aspiriant LLC first reported a position in Vanguard Short-Term Corporate Bond ETF in Q1 2017 and has held it in 37 quarters since.
  • Aspiriant LLC's Vanguard Short-Term Corporate Bond ETF position peaked at $19.1M in Q1 2017.
  • 1,456 funds tracked by Wall St. Rank held Vanguard Short-Term Corporate Bond ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.